PD-1 monoclonal antibody

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

1 competitor in Extensive-stage Small-cell Lung Cancer

Drug Information

Target Indication

Extensive-stage Small-cell Lung Cancer

Clinical Trial

Last updated: 4/22/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

SKBBY

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd./ADR

Related Pipeline

Urothelial Carcinoma

HR+HER2- Breast Cancer

Advanced Biliary Tract Cancer

Non-small Cell Lung Adenocarcinoma

HER2-positive Breast Cancer

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts